Ravulizumab (ALXN1210) is a humanized monoclonal antibody engineered to bind with high affinity to the human complement protein C5. This antibody is pivotal in the inhibition of the terminal complement cascade, a key component in immune response and inflammation. Ravulizumab is primarily utilized in the investigation of diseases such as paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis, offering a significant tool for understanding the pathophysiology and therapeutic interventions of these conditions.
Ravulizumab (ALXN1210) is a humanized monoclonal antibody engineered to bind with high affinity to the human complement protein C5. This antibody is pivotal in the inhibition of the terminal complement cascade, a key component in immune response and inflammation. Ravulizumab is primarily utilized in the investigation of diseases such as paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis, offering a significant tool for understanding the pathophysiology and therapeutic interventions of these conditions.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
